Studies have shown that elevated XRCC6 expression can confer radiotherapy resistance in tumor cells, including cervical and rectal cancer cells, potentially diminishing the effectiveness of radiotherapy [22,23]. This evidence concerns the gene XRCC6 and rectal cancer.